封面
市场调查报告书
商品编码
1482463

全球群勃龙庚酸酯市场:按类型、按应用、按分销管道、按地区

Trenbolone Enanthate Market, By Type, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球群勃龙庚酸酯市场规模将达7,560万美元,2024年至2031年复合年增长率为2.8%,2031年将达9,150万美元。

报告范围 报告详情
基准年 2023年 2024年市场规模 7560 万美元
实际资料 2019-2023 预测期 2024-2031
预测 2024-2031 年复合年增长率: 2.80% 2031 年金额预测 9150万美元
图:2024 年按地区分類的群勃龙市场占有率(%)
群勃龙庚酸市场-IMG1

群勃龙庚酸酯是一种雄性激素和合成代谢类固醇,是群勃龙的 17B-庚酸酯。它是诺龙的合成衍生物,对雄性激素受体具有强烈的结合亲和性。当用于增强表现或增强体质和表现时,庚酸群勃龙通常每週或每两週进行一次肌肉注射。它的一些显着的合成代谢特性包括增加蛋白质合成、氮保留和红血球生成。其雄性激素作用包括增强脂质动员、增加肌肉质量和力量。然而,与其他提高成绩的类固醇一样,庚酸群勃龙如果误用或滥用也会带来一定的健康风险。

市场动态:

全球群勃龙庚酸市场的成长是由运动员群体对群勃龙庚酸的需求不断增长所推动的,以提高成绩和增强体质。然而,有关合成代谢类固醇使用的严格规定正在阻碍市场成长。更安全的替代化合物的开发正在该领域创造新的机会。高利润率吸引製造商和供应商进入非法市场。需求是由优先考虑性能和美观效果而不是健康风险的用户驱动的。对不良后果缺乏认识仍然是公共卫生机构面临的挑战。

本研究的主要特点

  • 本报告提供了全球群勃龙庚酸酯市场的详细分析,包括以2023年为基准年的预测期(2024-2031年)的市场规模(百万美元)和年复合成长率(CAGR%)。 。
  • 它阐明了各个细分市场的潜在商机,并概述了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球群勃龙庚酸酯市场的主要企业。
  • 该报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球群勃龙庚酸酯市场迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过分析全球群勃龙庚酸酯市场时所使用的各种策略矩阵,将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 最近的趋势
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球群勃龙庚酸酯市场 - COVID-19 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球群勃龙庚酸酯市场:按类型划分,2019-2031 年(百万美元)

  • 庚酸群勃龙粉末
  • 庚酸群勃龙注射液

第六章全球群勃龙庚酸酯市场:依应用分类,2019-2031(百万美元)

  • 药品
  • 老兵专用医药

第七章全球群勃龙庚酸酯市场:依通路划分,2019-2031(百万美元)

  • 医院药房
  • 零售药房
  • 其他的

第八章全球群勃龙庚酸酯市场:按地区划分,2019-2031(百万美元)

第9章 竞争格局

  • 公司简介
    • Kosher Pharmaceuticals
    • LEXICARE PHARMA PVT. LTD.
    • Niva Lifecare
    • Dragon Pharma
    • Mulan Pharma Pvt. Ltd.
    • Cooper Pharma
    • Alpha-Pharma Healthcare
    • Genesis Global Pharma
    • Meditech Pharmaceutical
    • Gen-Shi Laboratories
    • Hilma Biocare
    • Horster Biotek Pvt. Ltd.
    • Actiza Pharmaceutical

第10章分析师建议

第十一章 参考文献与调查方法

简介目录
Product Code: CMI6886

Global trenbolone enanthate market is estimated to be valued at USD 75.6 Mn in 2024 and is expected to reach USD 91.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 2.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 75.6 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 2.80% 2031 Value Projection: US$ 91.5 Mn
Figure. Trenbolone Enanthate Market Share (%), By Region 2024
Trenbolone Enanthate Market - IMG1

Trenbolone Enanthate is an androgen and anabolic steroid, which is the 17B-enanthate ester of trenbolone. It is a synthetic derivative of nandrolone that exhibits strong binding affinity for the androgen receptor. When used for performance enhancement or physique- and performance-enhancing purposes, trenbolone enanthate is often administered via intramuscular injection in weekly or biweekly intervals. Some of its notable anabolic properties include increased protein synthesis, nitrogen retention, and red blood cell production. Its androgenic effects encompass enhanced lipid mobilization and increased muscle mass and strength. However, as with other performance-enhancing steroids, Trenbolone Enanthate also poses certain health risks if misused or abused.

Market Dynamics:

Global trenbolone enanthate market growth is driven by rising demand of trenbolone enanthate from performance-enhancing and physique-building athlete populations. However, stringent regulations around the use of anabolic steroids hamper the market growth. The development of safer alternative compounds provides new opportunities in this space. High profit margins attract manufacturers and suppliers to serve the illicit market. Users prioritizing performance and aesthetic results over health risks boosts its demand. Lack of awareness regarding harmful consequences remains a challenge for public health bodies.

Key Features of the Study:

  • This report provides in-depth analysis of the global trenbolone enanthate market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global trenbolone enanthate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Kosher Pharmaceuticals, LEXICARE PHARMA PVT. LTD., Niva Lifecare, Dragon Pharma, Mulan Pharma Pvt. Ltd., Cooper Pharma, Alpha-Pharma Healthcare, Genesis Global Pharma, Meditech Pharmaceutical, Gen-Shi Laboratories, Hilma Biocare, Horster Biotek Pvt. Ltd., and Actiza Pharmaceutical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global trenbolone enanthate market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global trenbolone enanthate market.

Detailed Segmentation-

  • Type:
    • Trenbolone Enanthate Powder
    • Trenbolone Enanthate Injection
  • Application:
    • Pharmaceuticals
    • Veterinary Medicine
  • Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Kosher Pharmaceuticals
    • LEXICARE PHARMA PVT. LTD.
    • Niva Lifecare
    • Dragon Pharma
    • Mulan Pharma Pvt. Ltd.
    • Cooper Pharma
    • Alpha-Pharma Healthcare
    • Genesis Global Pharma
    • Meditech Pharmaceutical
    • Gen-Shi Laboratories
    • Hilma Biocare
    • Horster Biotek Pvt. Ltd.
    • Actiza Pharmaceutical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Fundings and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Trenbolone Enanthate Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Trenbolone Enanthate Market, By Type, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Trenbolone Enanthate Powder
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Trenbolone Enanthate Injection
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Trenbolone Enanthate Market, By Application, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Pharmaceuticals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Veterinary Medicine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Trenbolone Enanthate Market, By Distribution Channel, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Trenbolone Enanthate Market, By Region, 2019 - 2031, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Kosher Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LEXICARE PHARMA PVT. LTD.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Niva Lifecare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dragon Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mulan Pharma Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cooper Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alpha-Pharma Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Genesis Global Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Meditech Pharmaceutical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Gen-Shi Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hilma Biocare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Horster Biotek Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Actiza Pharmaceutical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact